Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions PLN. Fiscal year is July - June.

Millions PLN. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 13, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	519	667	811	145	173	122	Upgrade
Market Cap Growth	-28.12%	-17.81%	458.28%	-15.98%	42.19%	-4.82%	Upgrade
Enterprise Value	507	643	806	135	157	110	Upgrade
Last Close Price	1.80	2.38	3.01	0.59	0.73	0.68	Upgrade
PS Ratio	441.02	540.17	957.36	179.40	203.15	97.60	Upgrade
PB Ratio	14.78	16.40	19.07	3.97	10.65	11.15	Upgrade
P/TBV Ratio	14.78	16.40	19.07	3.97	10.65	11.15	Upgrade
EV/Sales Ratio	-	520.86	950.90	167.09	184.13	88.63	Upgrade
Debt / Equity Ratio	0.01	0.02	0.04	0.07	0.03	0.11	Upgrade
Asset Turnover	0.03	0.03	0.02	0.02	0.04	0.06	Upgrade
Quick Ratio	2.84	4.14	5.21	2.70	2.98	1.97	Upgrade
Current Ratio	2.84	4.14	5.21	2.70	2.98	1.97	Upgrade
Return on Equity (ROE)	-29.54%	-29.50%	-25.60%	-41.81%	-18.16%	-58.50%	Upgrade
Return on Assets (ROA)	-13.51%	-14.69%	-12.91%	-23.69%	-13.07%	-23.94%	Upgrade
Return on Capital (ROIC)	-14.97%	-16.26%	-14.98%	-30.44%	-18.73%	-33.55%	Upgrade
Earnings Yield	-2.29%	-1.83%	-1.18%	-7.80%	-1.45%	-7.42%	Upgrade
FCF Yield	-1.96%	-2.06%	-1.62%	-9.46%	-3.71%	-8.46%	Upgrade
Buyback Yield / Dilution	-4.26%	-6.04%	-7.31%	-4.29%	-5.68%	-	Upgrade

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.